The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with L-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease - Archive ouverte HAL Access content directly
Journal Articles Journal of Pharmacology and Experimental Therapeutics Year : 2012

The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with L-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease

Carrie K. Jones
  • Function : Author
Michael Bubser
  • Function : Author
Analisa D. Thompson
  • Function : Author
Jonathan W. Dickerson
  • Function : Author
Nathalie Turle-Lorenzo
  • Function : Author
Anna L. Blobaum
  • Function : Author
Thomas M. Bridges
  • Function : Author
Ryan D. Morrison
  • Function : Author
Satyawan Jadhav
  • Function : Author
Darren W. Engers
  • Function : Author
Kimberly Italiano
  • Function : Author
Jacob Bode
  • Function : Author
J. Scott Daniels
  • Function : Author
Craig W. Lindsley
  • Function : Author
Corey R. Hopkins
  • Function : Author
P. Jeffrey Conn
  • Function : Author
Colleen M. Niswender
  • Function : Author

Abstract

no abstract

Dates and versions

hal-01384126 , version 1 (19-10-2016)

Identifiers

Cite

Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, Nathalie Turle-Lorenzo, et al.. The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with L-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease. Journal of Pharmacology and Experimental Therapeutics, 2012, 340 (2), pp.404-421. ⟨10.1124/jpet.111.187443⟩. ⟨hal-01384126⟩

Collections

CNRS UNIV-AMU LNC
46 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More